Ken H. Hoo

1.2k total citations
17 papers, 977 citations indexed

About

Ken H. Hoo is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Ken H. Hoo has authored 17 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 3 papers in Physiology. Recurrent topics in Ken H. Hoo's work include Neuroscience and Neuropharmacology Research (12 papers), Ion channel regulation and function (5 papers) and Receptor Mechanisms and Signaling (5 papers). Ken H. Hoo is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Ion channel regulation and function (5 papers) and Receptor Mechanisms and Signaling (5 papers). Ken H. Hoo collaborates with scholars based in United States, Canada and United Kingdom. Ken H. Hoo's co-authors include David Bleakman, Paul L. Ornstein, Allan Mandelzys, David Lodge, Barbara A. Ballyk, Rajender K. Kamboj, Ceri H. Davies, Darryle D. Schoepp, Graham L. Collingridge and Smriti Iyengar and has published in prestigious journals such as Nature, Journal of Medicinal Chemistry and European Journal of Pharmacology.

In The Last Decade

Ken H. Hoo

17 papers receiving 939 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken H. Hoo United States	14	787	659	153	138	86	17	977
Darryle D. Schoepp United States	14	893 1.1×	624 0.9×	161 1.1×	122 0.9×	85 1.0×	17	1.1k
Allan Mandelzys Canada	13	792 1.0×	848 1.3×	145 0.9×	74 0.5×	75 0.9×	14	1.2k
D.A.S. Smith United Kingdom	15	856 1.1×	626 0.9×	143 0.9×	122 0.9×	47 0.5×	21	1.1k
Roland Heckendorn Switzerland	8	884 1.1×	579 0.9×	198 1.3×	96 0.7×	71 0.8×	25	1.1k
David R. Helton United States	14	831 1.1×	614 0.9×	207 1.4×	120 0.9×	32 0.4×	22	1.1k
M Bertolino United States	14	816 1.0×	785 1.2×	85 0.6×	147 1.1×	85 1.0×	15	1.2k
Ann Marie L. Ogden United States	13	568 0.7×	429 0.7×	166 1.1×	74 0.5×	61 0.7×	17	846
C. Malgouris France	15	660 0.8×	455 0.7×	96 0.6×	83 0.6×	113 1.3×	25	947
D Lodge United Kingdom	14	1.1k 1.5×	811 1.2×	175 1.1×	240 1.7×	104 1.2×	26	1.5k
Ken H. Ho United States	9	544 0.7×	389 0.6×	142 0.9×	51 0.4×	52 0.6×	9	667

Countries citing papers authored by Ken H. Hoo

Since Specialization

Citations

This map shows the geographic impact of Ken H. Hoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken H. Hoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken H. Hoo more than expected).

Fields of papers citing papers by Ken H. Hoo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken H. Hoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken H. Hoo. The network helps show where Ken H. Hoo may publish in the future.

Co-authorship network of co-authors of Ken H. Hoo

This figure shows the co-authorship network connecting the top 25 collaborators of Ken H. Hoo. A scholar is included among the top collaborators of Ken H. Hoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken H. Hoo. Ken H. Hoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Pedregal, Concepción, Iván Collado, Ana Escribano, et al.. (2000). 4-Alkyl- and 4-Cinnamylglutamic Acid Analogues Are Potent GluR5 Kainate Receptor Agonists. Journal of Medicinal Chemistry. 43(10). 1958–1968. 29 indexed citations

Hoo, Ken H., Geihan Rizkalla, Tine B. Stensbøl, et al.. (1999). [3H]ATPA: a high affinity ligand for GluR5 kainate receptors. Neuropharmacology. 38(12). 1811–1817. 25 indexed citations

Bleakman, David, et al.. (1999). Pharmacological characterization of a GluR6 kainate receptor in cultured hippocampal neurons. European Journal of Pharmacology. 378(3). 331–337. 38 indexed citations

Small, Ben G., Mark I. Kemp, Ken H. Hoo, et al.. (1998). LY339434, a GluR5 kainate receptor agonist. Neuropharmacology. 37(10-11). 1261–1267. 34 indexed citations

Simmons, Rosa Maria A., et al.. (1998). Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat. Neuropharmacology. 37(1). 25–36. 137 indexed citations

O’Neill, Michael J., Ann Bond, Paul L. Ornstein, et al.. (1998). Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia. Neuropharmacology. 37(10-11). 1211–1222. 93 indexed citations

Jane, David E., et al.. (1998). ChemInform Abstract: Synthesis of Willardiine and 6‐Azawillardiine Analogues: Pharmacological Characterization on Cloned Homomeric Human AMPA and Kainate Receptor Subtypes.. ChemInform. 29(7). 30 indexed citations

Jane, David E., et al.. (1997). Synthesis of Willardiine and 6-Azawillardiine Analogs: Pharmacological Characterization on Cloned Homomeric Human AMPA and Kainate Receptor Subtypes. Journal of Medicinal Chemistry. 40(22). 3645–3650. 81 indexed citations

Clarke, Vernon R. J., Barbara A. Ballyk, Ken H. Hoo, et al.. (1997). A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature. 389(6651). 599–603. 349 indexed citations

10.

Cantrell, Buddy E., Dennis M. Zimmerman, James A. Monn, et al.. (1996). Synthesis of a Series of Aryl Kainic Acid Analogs and Evaluation in Cells Stably Expressing the Kainate Receptor humGluR6. Journal of Medicinal Chemistry. 39(19). 3617–3624. 30 indexed citations

11.

Korczak, Bożena, Stephen L. Nutt, Elizabeth J. Fletcher, et al.. (1995). cDNA cloning and functional properties of human glutamate receptor EAA3 (GluR5) in homomeric and heteromeric configuration.. PubMed. 3(1). 41–9. 25 indexed citations

12.

Korczak, Bożena, et al.. (1995). Expression and characerization of human kainate receptor subunits in Escherichia coli and mammalian cells. Drug Development Research. 34(3). 260–266. 1 indexed citations

13.

Hoo, Ken H., Stephen L. Nutt, Elizabeth J. Fletcher, et al.. (1994). Functional expression and pharmacological characterization of the human EAA4 (GluR6) glutamate receptor: a kainate selective channel subunit.. PubMed. 2(4). 327–37. 31 indexed citations

14.

Nutt, Stephen L., Ken H. Hoo, Candace E. Elliott, et al.. (1994). Molecular characterization of the human EAA5 (GluR7) receptor: a high-affinity kainate receptor with novel potential RNA editing sites.. PubMed. 2(4). 315–26. 36 indexed citations

15.

Hoo, Ken H., C.Y. Kwan, & E. E. Daniel. (1994). Investigation of α₁-adrenoceptor subtypes in canine aorta, using alkylating agents. Canadian Journal of Physiology and Pharmacology. 72(1). 97–103. 11 indexed citations

16.

Daniel, E. E., et al.. (1991). Alpha-Adrenoceptors in Vascular Smooth Muscle: All Is Not Well. Journal of Vascular Research. 28(1-3). 104–114. 12 indexed citations

17.

Quilliam, Michael A., et al.. (1987). Identification of the photolysis products of nitrofurazone irradiated with laboratory illumination. Canadian Journal of Chemistry. 65(5). 1128–1132. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact